1 completed, 1 not yet recruiting, 1 withdrawn. 2 Phase 2, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Not yet recruiting 1 |
Follow ferrous citrate: new trials by email Literature Review of ferrous citrate trials Research Report on ferrous citrate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FIA Acute Inflammation ⁵⁷Fe-labelled ferrous sulphate, ⁵⁸Fe-citrate - Inflammation, Iron Absorption | Not applicable | Not yet recruiting | University of Zurich | 48 | 2026-11-09 | 2026-11-12 |
| Treatment With 5-AminoLEvuliNic Acid Before Cardiac Surgery 5-Aminolevulinic Acid hydrochloride (5-ALA), Placebo, Sodium ferrous citrate (SFC) - Cardiac Surgical Procedures, Coronary Artery Bypass | Phase 2 | Completed | University of Oxford | 48 | 2021-02-01 | 2025-06-25 |
| A Study to Assess the Safety and Efficacy of 5-aminolevulinic Acid Hydrochloride (5-ALA HCl) and Sodium Ferrous Citrate (SFC) Added on Artemisinin-based Combination Therapy (ACT) in Adult Patients With Uncomplicated Malaria 5-aminolevulinic acid hydrochloride (5-ALA HCl) 600 mg QD, Sodium ferrous citrate (SFC) 472 mg QD, Artemisinin-based combination (ACT) - Malaria | Phase 2 | Withdrawn | Neopharma Japan Co., Ltd. | 2019-09-06 | 2020-03-03 |
Aortic Valve Disease (1) · Community-Acquired Pneumonia (1) · Inflammation (1) · Iron Metabolism Disorders (1) · Malaria (1)
Neopharma Japan Co., Ltd. (1) · University of Oxford (1) · University of Zurich (1)
Switzerland (1) · United Kingdom (1)
Arash Yavari, DPhil MRCP (1) · Dominik J Schaer, Prof (1) · Florence Vallelian, Prof (1) · Raphael M Buzzi, MD PhD (1)